Advances in Minimally Invasive Liver Resection for Cancer Therapies
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: closed (1 May 2023) | Viewed by 23864
Special Issue Editor
Interests: liver resection; laparoscopic liver resection; hepatocellular carcinoma; liver metastasis; chemotherapy (neoadjuvant, induction); liver venoocclusive disease; anus neoplasms; intensity modulated radiation therapy; chemoradiotherapy
Special Issue Information
Dear Colleagues,
For the initial 30 years after the first report of laparoscopic liver resection (LLR) in 1991, minimally invasive liver resection has been developing rapidly with less invasiveness (especially for patients with deteriorated liver function). Resections in anterolateral segments (segments 2, 3, 4a, 5, 6) and left lateral sectionectomy are now common procedures. Left and right hemi-hepatectomies are often performed, and sectionectomies of left median, right anterior and posterior are also now common procedures in many centers. Partial resection and segmentectomies in posterosuperior segments (segments 1, 4b, 7, 8), repeat LLR and combinations of small anatomical resection and hepatic vein-guided resection are now being established as common generalized approaches that many centers can adapt to common practice.
Preoperative simulation and intraoperative navigation with/without anatomical resections (CT-based simulation, US-guided navigation, ICG/florescence-guided navigation for anatomical boundary and tumor localization, etc.) are now under investigation. Though liver cancers of metastasis (mainly colorectal origin), hepatocellular carcinoma, and intrahepatic cholangiocellular carcinoma are the main indications for LLR besides benign diseases, its use in biliary tract cancers, including gallbladder carcinoma and perihilar carcinoma with bile duct/vascular resection/reconstruction, are now under discussion. The advantages/disadvantages and indications of robot-assisted liver resection compared to usual LLR should be investigated. Furthermore, re-evaluations and discussions of the results from currently performing LLR should be done.
This Special Issue of Cancers is dedicated to clarifying the above-listed points with the aim of stimulating further discussion and taking further steps in implementing minimally invasive liver resection as a cancer therapy.
Prof. Dr. Zenichi Morise
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- laparoscopic liver resection
- minimally invasive liver resection
- deteriorated liver function
- anatomical resection
- preoperative simulation
- intraoperative navigation
- liver metastasis
- hepatocellular carcinoma biliary tract cancers
- robot-assisted liver resection